For one study, 12 people with eczema, psoriasis, or seborrheic dermatitis had a thin layer of honey applied to skin lesions daily. In most cases, their symptoms improved significantly after a week.

Sun Pharma’s experimental drug SCD-044 did not meet its main goals in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue further development.

Eczema, a form of dermatitis, is a common skin concern affecting ... are ideal for inflammatory skin conditions like eczema and psoriasis because they can help relieve itchiness, dryness and ...

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic ...

Atopic dermatitis flares are the result of different ... including skin cancer, acne, rosacea, eczema, and psoriasis. Dr. Rose believes in a comprehensive approach to skin health and incorporating ...

Sun Pharma has discontinued the development of SCD-044 after Phase 2 trials failed to meet primary goals in treating psoriasis and atopic dermatitis despite rigorous testing ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company announced disappointing results from Phase 2 trials of its experimental drug, ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its continued development. The company and its partner, Sun Pharma Advanced ...